A B ST R A CT The transit of '4C02 and H'4CO3 through the renal vasculature was studied in rabbit kidneys perfused without erythrocytes and in an in vivo preparation in which erythrocytes were present. In the absence of erythrocytes, the transit of 14CO2 from the renal artery to renal vein was much more rapid than that of H'4CO3. This suggests that (a) there is insufficient carbonic anhydrase (c.a.) in the vasculature between the renal artery and the exchange vessels of the kidney to ensure equilibration between CO2 and HCO3 and (b) CO2 can diffuse directly between arterial and venous vessels in the kidney. Following infusions of carbonic anhydrase, the renal venous outflow patterns of '4CO2 and H'4CO3 became the same in the perfused kidneys. Although the initial recovery of 14CO2 remained greater than that of H'4CO3 after infusions of acetazolamide (a c.a. inhibitor), arteriovenous diffusion of "4CO2 was diminished by this agent. This is attributed to inhibition of renal tubular c.a.
INTRODUCTION
Evidence for endothelial carbonic anhydrase (c.a.)' in the lung and leg has now been obtained by indicator dilution procedures (1) (2) (3) (4) (5) and a variety of other physiological, histochemical, immunocytologic, and cytochemical procedures (6) (7) (8) (9) (10) (11) (12) . This enzyme is associated with the same membranes that have angiotension converting enzyme activity and is apparently located on the outer surface of the endothelial cell. Endothelial c.a. is presumably more accessible to plasma bicarbonate than the erythrocyte enzyme, which seems to be strictly intracellular. Whitney and Briggle (13) have successfully isolated the endothelial enzyme from the lung and shown that it differs in molecular weight, composition, and activity from erythrocyte c.a. Synthesis of the enzyme by cultures of bovine pulmonary artery endothelial cells has also been documented (12) .
Recently, DuBose et al. (14) suggested that there may be insufficient c.a. accessible to HCO-in the renal vessels or interstitium to ensure equilibration with CO2. Utilizing the same indicator dilution approach that demonstrated the presence of c.a. activity in the vessels of the lung and leg, we have obtained data indicating that there is not enough c.a. associated with the renal endothelium to ensure equilibration between '4C02 and H'4CO-in the absence of erythrocytes. Equilibration was promoted by erythrocytes in the intact animal but may nevertheless be incomplete in the renal capillaries and/or interstitium.
METHODS

General procedures
In the initial in vitro studies, comparisons were made between the transit 14CO2 and H14CO-from the renal artery to renal vein in kidneys perfused with artificial solutions not containing erythrocytes or c.a. The basic premise was that if the outflow patterns of H'4CO-and '4C02 were different, then there is insufficient c.a. on the renal arterial and exchange vessels to ensure equilibration between these indicators. The effects of c.a. and acetazolamide upon transit of these indicators through the kidney were also determined. The studies were then repeated with an in vivo preparation in which the kidneys were perfused with erythrocytes to see if erythrocyte c.a. is sufficiently accessible to permit equilibration between 14CO2 and H'4CO-An in vivo preparation was used to minimize hemolysis that might occur in kidneys artificially perfused with erythrocyte suspensions. Additional studies were conducted to determine the effect of acetazolamide upon extravascular pH in the in vitro kidney. The effect of injections and infusions of c.a. upon the exchange of equilibrated mixtures of "4CO2 and H'4CO-was investigated in the in vivo preparation.
The significance of differences between mean values were determined by analysis of variance with either repeated measures or randomized design (Tukey test).
In vitro kidney studies Experimental preparations. 16 albino New Zealand rabbits weighing between 2.3 and 3.3 kg were injected with 12 ml of a 25-g/dl mannitol solution and 200 mg of sodium heparin in an ear vein. 5 min later they were sacrificed with 150 mg pentobarbital administered by the same route. The abdominal cavity was then opened and polyethylene catheters (PE 90) were placed in the renal artery and vein of the left or right kidney. A small catheter (PE 50) was inserted in the ureter. The kidney was removed and placed in a dish mounted in a 370C bath (see Fig. 1 ). Blood was flushed from the kidney both before and after removal with several hundred milliliters of perfusion fluid. This served to lower c.a. levels in the renal venous outflow to <0.0001 of that in the rabbit blood cells (as determined by the Hodgen and Falk procedure) (15 Simultaneous injections of 0.09 ml of an alkaline solution and 0.09 ml of an acid solution were made through a small T-tube into the renal arterial catheter within a 1-s interval. These solutions were adjusted so that when equal volumes were mixed, the pH of the solution would promptly become 7.4 . In half of the runs, NaH'4C03 was included in the alkaline solution to yield H'4CO. In the other half, it was placed in the acid solution to produce "4CO2. The acid solution contained 12 mM HCl in 0.1 g/dl bovine serum albumin-saline solution and the alkaline solution contained 30 mM of the buffer Hepes in Ringer's lactate at pH 8.4. Hepes buffer was used rather than a CO2-HCO-system to ensure that a constant pH was rapidly attained. In contrast, equilibration of "CO2 and H'4CO3 proceeded slowly at the uncatalyzed rate in the absence of carbonic anhydrase. Because of the small dimensions of the injection catheter assembly, only 0.014 ml of each solution remained in the injection tubing after injection and the delay from the point of injection to the renal artery averaged 0.05 s.
Radioisotopes were added to the acid or alkaline injection solutions 1 h before injection. Each injection contained 0.8 yCi '25I-albumin, and 5 ,uCi (121 nmol) NaH'4C0 .
Measurements of extravascular pH were conducted with single injections of 0.09 ml containing '25I-albumin, 0.22 ACi of [2-14C1 5,5-dimethyl-2,4-oxazolidine dione (DMO, 4 nmol) and 4 ACi3H2O.
Sample collection. Fluid was pumped at a rate just under that of the venous outflow through a side arm in the venous outflow catheter. The fluid was collected at 0.75-s intervals into syringes mounted on an anaerobic collector (see Fig. 1 ). The venous outflow was augmented by an equal flow of saline to be sure there was sufficient fluid in each syringe to minimize dilution from the perfusion fluid placed in the dead space of these syringes. This was accomplished by ganging two identical Cole-Parmer peristaltic heads (Cole Parmer, Chicago, IL) on the collection pump. The delay between the renal vein and collection syringes averaged 2.5 s. In the pH studies, the renal venous outflow was collected directly into cuvettes at 0.7-s intervals with an aerobic collector.
Sample measurements and data analysis. Aliquots of 0.2 ml were withdrawn from each syringe and delivered with 10 ml of 15% phenethylamine in Aqueous Counting Scintillant (Amersham Corp., Arlington Heights, IL) into scintillation vials. Pure isotope standards and injection fluid standards were made in the perfusion fluid and processed in the same manner.
Gamma and beta activities were determined in multichannel, multiple sample counters. Corrections were made for crossover between channels and the radioactivities of each sample were divided by the amounts of each isotope injected to yield fractional concentrations (milliliters-').
The fractional concentrations of each indicator were plotted against time as indicated in Figs. 2 and 3. The areas under each of these curves were calculated from the time of appearance to the peak of the 1251-albumin curves. The calculated areas were divided by those of '251-albumin to yield the ratios, R1. Values of RI were used to compare the initial recovery of each indicator relative to '25I-albumin in the venous outflow (see below). The total recovery of each indicator relative to that of '251-albumin and the indicator mean transit times, t, were calculated from the indicator dilution curves extrapolated on semilogarithmic coordinates as described previously (16) . Renal blood flow was calculated from the area under the '25I-albumin curve. The The pH of the perfusate was measured in the reservoir during the runs and did not change significantly in the c.a. runs (pH averaged 7.43±0.01 SD). A small rise in pH (0.03 U) occurred in the acetazolamide studies (control pH = 7.43±0.01 SD, acetazolamide pH = 7.46±0.01 SD). To be sure that neither this difference nor the sequence of studies affected the data, an 11th study was performed in which pH was more closely regulated and acetazolamide was administered in the initial two runs. Following a 10-min flush with perfusate not containing acetazolamide, recontrol studies were obtained. The data closely resembled that found in the other five acetazolamide studies and the data of this experiment were not included in the statistical analysis.
In the five pH studies, control experiments were followed by infusions of acetazolamide.
1420
R. M. Effros and S. Nioka In vivo kidney studies Experimental preparation. 27 albino New Zealand rabbits with average weights of 2.64±0. 35 (SD) kg were anesthetized with 8-12 ml of a 10-mg/ml solution of sodium pentobarbital into an ear vein and a cannula was placed in the trachea. The animals were ventilated 30 times per minute with a tidal volume of 15-20 ml of room air. The abdomen was then opened and catheters were placed in the right or left renal vein, renal artery, aorta, and ureter as shown in Fig. 1 . Perfusion of the kidney was accomplished by connecting the aortic and renal artery catheters with a polyethylene tube that had a side arm. 60 ml of 25 g/dl mannitol and 2 ml of a 1,000-U/ml solution of sodium heparinate were administered through the ear vein and 0.2 ml of a 3-mg/ml papaverine hydrochloride solution was injected in an ear vein or the renal artery catheter. Urine flow remained low in these studies and was not collected. Kidney weight averaged 9.64±1.25 (SD) g at the end of the study.
Injection solutions. The injection solutions used for the double injection studies in the in vivo studies were the same as those used for the perfused kidneys. 3H20 was included in the injection solutions of most of these experiments to provide a second reference curve to which the 14C curves could be compared. In addition, six studies were conducted in which 0.09 ml of a single solution containing an equilibrated mixture of H14CO-and'4C02 at pH 7.4 was injected into the renal artery. Sample collections. Fluid was pumped from the renal venous catheter at 3.85 ml/min with a peristaltic pump into syringes mounted on an anaerobic collector. Each syringe was filled for 1 s. The outflow (Fig. 1 ) was diluted with a flow of 13 Sample measurements and analysis. To minimize quenching, small volumes (0.05 ml) of the collected samples were added to 10 ml of 15% phenethylamine. The ratio of the area under the 14C curve to that of the '25I-curve was calculated as described above. A comparable ratio, RH, of 14C area to 3H20 area (up to the time that the peak of the '25I curve was reached) was also calculated in those experiments in which 3H20 was included in the injection bolus. It was reasoned that the outflow patterns of neither '25I-albumin nor 'H20 would be influenced by whether 14CO2 or H'4CO-injections were made because this distinction was Carbonic Anhydrase Deficiency in Renal Vessels Experimental protocols. The double injection procedure was used in each of the first two studies. In the first study (Figs. 5 and 6 ), 14CO2 and H"4CO3 were injected alternately into the renal artery catheter with '25I-albumin. Thereafter 50 mg/kg acetazolamide (Lederle Laboratories), an inhibitor of c.a., was injected intravenously and the renal artery injections were repeated.
In the second study (Fig. 7) , the control studies were followed by intravenous injections of 25 In a third study (Fig. 9) 
RESULTS
In vitro experiments. Under control conditions, the passage of 14CO2 through the kidney perfused without erythrocytes was much more rapid than that of H14CO-(see upper panels of Figs. 2 and 3) . The initial recovery, R, of 14C after injections of 14CO2 exceeded that following injections of H14CO-by a factor of more than four (Fig. 4) . Furthermore, the mean transit times of 14CO2 were significantly shorter than those of H'4CO-(T,4c1s was only one-third of TH14co. In 9 of 10 control studies, the fractional concentration of 14CO2 actually exceeded that of 1251-albumin (by an average factor of 5.6±2.4 SEM) in the first collection tube that contained radioactivity. This never occurred with H 34CO-After perfusion of the kidney with 200 mg/liter c.a., the outflow patterns of 14CO2 became very similar to those of H14CO-(lower panels of Fig. 2 ). This similarity was reflected in terms of both the initial recovery and mean transit times of these indicators (Fig. 4) . Changes in H14CO-parameters were not significant.
Perfusion with acetazolamide also slowed 14CO2 transport through the kidney but did not have as great an effect on initial recovery of 14CO2 as c.a. (lower panels of Fig. 3 ). The initial recoveries of 14CO2 fell significantly from control values (P < 0.01), but remained significantly greater than those of H'4CO-af- This change is most easily evaluated by dividing the In theory, the mean transit time of each indicator should be determined by its virtual volume of distribution within the kidney rather than the manner in which it traverses the organ (27) . The observation that the mean transit time of 14C02 was shorter than that of H14CO-probably reflects the fact that the collection periods were limited to a 40-s interval and the late efflux of 14C02 from more remote compartments of the kidney was not given sufficient weight. The fact that recovery of 14CO2 seemed complete in comparison to 1251-albumin does not ensure that the monoexponential outflow pattern assumed in these studies is correct or that the calculated mean transit times are appropriate. The late emergence of a small amount of indicator could significantly lengthen the mean transit time of 14CO2.
In contrast to 14CO2, diffusional shunting of H14CO-from arterial to venous vessels seems relatively limited. The renal vessels, like those of the lung and leg, appear to be much less permeable to this ion than to 14CO2. Alternatively, structures that separate arterial and venous vessels may be impermeable to these ions. H 34CO3 is presumably delivered with '251-albumin to the nephrons by the peritubular capillaries.
Unlike '251-albumin, it then diffuses into the extravascular compartment and consequently arrives in the renal venous blood at a later time than either '251-albumin or 14CO2.
The site at which "4CO2 or other lipophilic solutes diffuse from arterial to venous vessels cannot be determined from outflow studies. Since 90% of the renal blood flow is cortical (28) , it is likely that much of the shunting found in outflow experiments occurs in the renal cortex. A close proximity is found between arteries and veins in the interlobar, arcuate, and interlobular vessels and some exchange could occur between these adjacent flows. Even more shunting would be expected between adjacent capillaries. The interlobular arteries extend into the cortex in a radial fashion, giving rise to successive generations of afferent arterioles, which in turn supply the glomeruli. The efferent arterioles drain the glomeruli and form a complex, but continuous network of capillaries that surrounds the tubules. In more than half of these capillaries, flow is in the opposite direction to that of tubular fluid in the neighboring nephron (29) . It is quite likely that diffusion of lipophilic solutes injected into the renal artery could diffuse between adjacent capillary segments in a manner that would hasten their emergence from the kidney.
Diffusion of CO2 between adjacent vessels may also contribute to high Pco2 and HCO3 concentrations found in the efferent arteriolar blood on the kidney surface (14) . CO2 generated within the superficial cortex might diffuse from venous to arterial vessels in a countercurrent fashion that would tend to keep Pco2 elevated in this region. Equilibration with HCO3 would be approached in the blood, thereby elevating regional blood HCOj concentrations. Such a diffusional shunt of CO2 produced within the cortex might occur between interlobular vessels or adjacent capillary segments. Since less energy need be expended to maintain a Pco2 gradient over a greater distance (e.g., between the superficial and deep cortex) than over a shorter distance (e.g., between different portions of a nephron), the hypothesis of macroscopic countercurrent mechanism is appealing. Shunting of heat between arterial and venous vessels has been reported and is thought to be responsible for slow clearance of this extremely "diffusible" indicator from the superficial cortex (23, 24) . Similarly, it has been suggested that diffusion of ['251 ]iodoantipyrine between deeper cortical vessels may be responsible for the observation that blood flow estimated in the more superficial regions is less than that obtained with microspheres (30) . The observation that Pco2 is not elevated in tubular fluid of the medulla is also consistent with countercurrent diffusion in the cortex (31) .
The distinctly different outflow patterns of "'CO2
and H"'CO-indicate that there is insufficient c.a. on the luminal surface of the renal arteries or exchange vessels initially encountered by the perfusion fluid to ensure equilibration between these radionuclides. This hypothesis is confirmed by the observation that the outflow patterns of "'CO2 and H"4COQ become the same when c.a. is added to the perfusate. Histochemical studies have shown that there is abundant c.a. associated with the cytoplasm and membranes of many of the tubular epithelial cells (32) (33) (34) (35) (36) Following administration of acetazolamide, the initial appearance of 14CO2 remained earlier than that of H14CO-but '4CO2 transit through the kidney was clearly slower than under control conditions. This observation was unexpected and suggested that a more complete model of CO2 exchange was needed. There are three ways in which the acetazolamide effect upon "4CO2 could be explained.
(a) If acetazolamide increases the average pH of the extravascular compartments of the kidney, a prolongation and lowering of the outflow pattern of "4CO2 would be expected. This effect of increasing the relative pH of the extravascular space has been observed in indicator dilution studies of the lungs and myocardium (16, 18, 19) . Since no significant changes in mean extravascular pH were detected in this preparation with transient studies using the pH indicator, ["4C]DMO, this hypothesis seems unlikely.
(b) If c.a. is located specifically on the luminal surface of the more venous vessels of the kidney, conversion of 14CO2 diffusing into these vessels to H"4CO-would lower local concentrations of 14CO2 and encourage diffusional shunting from arterial to venous vessels. Inhibition of c.a. at this site would make this process less efficient. As indicated above, the enzyme has been detected on the postglomerular capillaries of some species (primates not rats) (32) (33) (34) (35) (36) . However, there is also abundant enzyme activity associated with the tubular epithelium and it is likely that much of the "4CO2 that escapes from the renal vessels is converted to H"'4CO3 in the extravascular compartments of the kidney. There is consequently little reason to believe that such a mechanism would effectively direct "4CO2 into the renal venous outflow.
(c) A more plausible explanation for the effect of acetazolamide is based upon the possible role of tissue c.a. in accelerating the conversion of H'4CO to "CO2 at the interface between aqueous and lipid phases at the cell surfaces. This hypothesis is based upon three assumptions:
( (38) . Furthermore it is also possible that enzyme located on cell membranes could transport H'4CO3 FIGURE 10 Schematic diagram of 14C02 and H'4CO-transit through the kidney in control studies after an injection of 14C02 (isotope numbers deleted for clarity). The bent cylinder represents the exchange vessels of the renal cortex, whereas the plane indicates a lipid cell membrane that is assumed to be associated with c.a. The movement of 14CO2 is by direct diffusion from the arterial to venous portions of the microcirculation (B to E). Some 14C02 is converted to H'4CO( within the vessels at the uncatalyzed rate. The HJ4CO3 is then carried by blood flow through the vessels from B to E, a process that requires more time than direct 14C02 diffusion between these points. Much of the '4C02 that escapes from the vessel is converted to H'4CO-at the uncatalyzed rate in the interstitium (C) or at the catalyzed rate on the cell membrane surface (D).
across the lipid barrier. When renal c.a. is inhibited by acetazolamide, whatever 14CO2 that has been converted to H14CO-at the uncatalyzed rate (C) will no longer be rapidly reconverted to 14CO2 at the cellular borders (D). That this is the correct explanation for the acetazolamide data is suggested by the observation that although initial outflow concentrations of 14CO2 are higher than those of H14CO-after infusions of acetazolamide, subsequent washout of 14C is relatively slower. Presumably with the passage of time, more of the 14CO2 that remains outside of the vessels is converted to H14CO-at the uncatalyzed rate.
Although a disequilibrium of "'CO2 and H"'CO3 occurs in some of the renal vessels in these perfused kidneys, it cannot be concluded that a similar disequilibrium would also be observed in vivo. There is considerable enzyme within erythrocytes that might promote equilibration between 14CO2 and H14CO-in the vascular compartment. Indeed, the studies with the in vivo kidney preparation indicate that in the presence of erythrocytes, the outflow patterns of these radionuclides are nearly the same. Infusions of acetazolamide inhibited c.a. in the erythrocytes as well as the kidney and the outflow patterns of 14CO2 and H14CO-again become dissimilar. However, the fact that equilibration is almost reached by the time the indicators are delivered from the renal artery to the capillaries does not prove that equilibrium is sustained within the capillaries. If the movement of 14CO2 from the capillaries is sufficiently rapid and the dehydration of H'4CO-is sufficiently slow, a disequilibrium between these radionuclides will be generated in the capillaries, which could limit tissue exchange. That this might indeed be the case is suggested by the experiments with c.a., which seemed to accelerate the movement of both 14C02 and H'4CO-through the kidney. The observation that the effect upon H14CO transport was slightly greater than that upon 14CO2 is difficult to explain and may have been due to an artifact (such as some '4C02 loss from the acidic injection syringes). In order to confirm that c.a. does accelerate "4C exchange, single injections containing 5% 14C02 and 95% H'4C03 were given into the renal artery. Addition of c.a. to the injection solution did increase RH and this effect was further increased by infusions of the enzyme. The greater effect of the infusions could reflect diffusion of the enzyme to some extravascular sites that are relatively deficient in c.a. activity. It has been proposed by Roughton (39) and Forster and Crandall (40) that because the erythrocyte enzyme is strictly intracellular, delays in equilibration are inevitable. The absence of carbonic anhydrase bound to the surface of endothelial cells might be responsible for some degree of disequilibrium within the renal vessels in vivo.
It is by no means obvious why the renal endothelium, unlike that of the leg or lung, is deficient in c.a. activity. In contrast to the pulmonary epithelium, which seems devoid of c.a. (4, 10) , and the muscle cells, which contain a very inactive form of the enzyme (41) (42) (43) , there is abundant c.a. activity associated with both the cytoplasm and membranes of many renal tubular cells (32) (33) (34) (35) (36) . There may, consequently, be little need for additional c.a. in the kidney vasculature. Because the renal tubular cells secrete hydrogen ions into the tubular lumen, the cells themselves are alkaline relative to the plasma and presumably the interstitium as well (44, 45 
